Aducanumab: A Deep Dive into BIIB037 and its Impact This drug, originally known as BIIB037, is a notable attempt to treat mild Alzheimer's illness. Designed by Biogen, this molecule functions by removing amyloid https://www.targetmol.com/compound/aducanumab